Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-17-022303
Filing Date
2017-09-19
Accepted
2017-09-19 21:09:21
Documents
1
Period of Report
2017-09-15

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 8432
  Complete submission text file 0000899243-17-022303.txt   10713
Mailing Address 8 CROSS STREET #10-00 SINGAPORE U0 048424
Business Address 8 CROSS STREET #10-00 SINGAPORE U0 048424 617-206-4830
Wave Life Sciences Ltd. (Issuer) CIK: 0001631574 (see all company filings)

EIN.: 000000000 | State of Incorp.: U0 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 6-1-20, NANEI KAGOSHIMA CITY KAGOSHIMA M0 891-0122
Business Address 6-1-20, NANEI KAGOSHIMA CITY KAGOSHIMA M0 891-0122 81-99-260-3311
Kagoshima Shinsangyo Sousei Investment Limited Partnership (Reporting) CIK: 0001657769 (see all company filings)

State of Incorp.: M0 | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-37627 | Film No.: 171093154

Mailing Address C/O WAVE LIFE SCIENCES LTD. 733 CONCORD AVE. CAMBRIDGE MA 02138
Business Address
Tanaka Masaharu (Reporting) CIK: 0001657771 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37627 | Film No.: 171093155